A Randomized Double Blinded Placebo-Controlled Phase III Trial Comparing Cyclosporine Plus Steroids With or Without Myfortic as Primary Treatment for Extensive Chronic Graft Versus Host Disease
Phase of Trial: Phase III
Latest Information Update: 06 May 2014
At a glance
- Drugs Mycophenolate sodium (Primary) ; Ciclosporin; Prednisone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 01 Sep 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 01 Sep 2009 Actual patient number (34) added as reported by ClinicalTrials.gov.
- 01 Sep 2009 Planned end date changed from 1 Sep 2008 to 1 Nov 2010 as reported by ClinicalTrials.gov.